Olmecar 40mg 10pcs Price in Bangladesh

Indications

Olmecar 40 is a medication used to treat heart failure and high blood pressure. Blood pressure reduction aids in reducing the risk of future heart attacks and strokes. Using this medication can help diabetic patients maintain kidney function.

Pharmacology

The essential vasoactive hormone of the renin-angiotensin system and a key player in the pathophysiology of hypertension, angiotensin-II is formed from angiotensin-I in a reaction catalyzed by angiotensin-converting chemical (Expert). It also stimulates the adrenal cortex's release of aldosterone. By specifically preventing angiotensin-II from binding to the AT 1 receptor, which is present in many tissues (including vascular smooth muscle and the adrenal organ), olmesartan blocks the effects of angiotensin-II that cause the release of aldosterone and vasoconstriction. Olmesartan may be a reversible and competitive inhibitor of the AT 1 receptor, according to in-vitro binding studies. Expert (kinase-I, the protein that converts angiotensin-I to angiotensin-II and corrupts bradykinin) is not suppressed by olmesartan.

Dosage & Administration

• Measurement must be individualized.
• Olmesartan is typically started at a dose of 20 mg once daily when used as monotherapy in patients who are not volume-contracted.
• After two weeks of treatment, the dosage of olmesartan may be increased to 40 mg for patients who need to promote blood weight loss.
• Over-40 mg doses don't seem to have a more noticeable effect.
• The same dosage administered twice daily has no advantages over the same dosage administered once daily.
• For elderly patients, patients with direct-to-stamped renal disability (creatinine clearance 40 ml/min), and patients with direct-to-checked hepatic brokenness, no beginning measurement adjustment is recommended.
• Olmesartan should be started under close medical supervision in patients who may experience intravascular volume exhaustion (such as those taking diuretics, particularly those with impaired renal function), and consideration should be given to using a lower starting dose.
• Olmesartan can be administered with or without food.

Interaction

The risk of hyperkalemia is increased by ACE inhibitors, K-sparing diuretics, K salts, K supplements, and medications that could raise serum K levels (e.g. ciclosporin, eplerenone). BP-lowering effects from other antihypertensives may be enhanced. NSAIDs may lower glomerular filtration, which can lead to acute renal failure. Lithium toxicity and serum concentrations may rise.

Contraindications

Olmesartan is contraindicated in patients who are extremely touchy with any component of this item.

Side Effects

• Cough
• Diarrhea
• Dizziness
• Flu-like signs
• Headache
• Indigestion
• Nausea
• Hyperglycemia
• Bronchitis
• Back torment
• Clogged nose
• Throat ache Stomach ache

Pregnancy & Lactation

Pregnancy: If you find out you're pregnant, stop using this product as soon as you can. Drugs that act directly on the renin-angiotensin system during the first and third trimesters of pregnancy can be harmful and even pass to the developing fetus.

Nursing Mothers: Olmesartan is discharged at low concentrations in the drain of lactating rats, but it is unknown if Olmesartan is excreted in human waste. Given the potential for negative effects on the nursing newborn child, a decision should be made regarding whether to stop the sedate or stop nursing, taking into account the significance of the sedate to the mother.

Precautions & Warnings

Changes in renal function may be anticipated in susceptible patients receiving olmesartan medoxomil due to the framework's restraint. Treatment with angiotensin-converting protein inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or dynamic azotemia and (rarely) with intense renal disappointment and/or passing in patients whose renal function may depend on the action of the renin-angiotensin-aldosterone framework (e.g. patients with severe congestive heart failure). Similar results could be anticipated in patients receiving olmesartan medoxomil.

Storage Conditions

Protect from light and moisture by storing in a cool, dry location. Keep out of children's reach.